
Astrocytoma is a type of glioma originating from star-shaped astrocyte cells in the brain, ranging from relatively slow‑growing (grades I–III) to the highly aggressive grade IV form, glioblastoma. In the U.S., gliomas occur at about 6 cases per 100,000 people annually, with glioblastoma accounting for approximately 61 % of those and...

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a highly targeted cancer treatment used for tumors that have spread within the abdominal cavity. Unlike standard chemotherapy, HIPEC delivers heated, high-dose drugs directly into the abdomen after surgical tumor removal, allowing for stronger local action with fewer systemic...

Esophageal cancer remains one of the most lethal malignancies of the digestive tract, responsible for approximately one in twenty cancer-related deaths globally. More than 500,000 new cases were diagnosed worldwide in 2022, with the burden especially high in East Asia and certain regions of Africa. In the United States...

Endometrial cancer is the most common gynecologic malignancy in Europe. According to the European Cancer Information System (ECIS), supported by the European Network of Cancer Registries (ENCR), there were approximately 125,000 new cases of endometrial cancer diagnosed across Europe in 2022, accounting for nearly...

Stomach cancer remains a serious global health concern, with over 1 million new cases diagnosed each year and approximately 770,000 deaths worldwide. While incidence rates have been declining in some regions due to better screening and dietary changes, late diagnosis and aggressive disease progression continue to make gastric...

Hearing the words "stomach cancer" can feel like the ground disappears beneath you. Fear, confusion, and a flood of questions – with no time to waste. What happens next? What are the treatment options? Is there hope for recovery? This guide is here to give you clarity in the chaos. We’ve gathered clear, reliable, and up-to-date information to walk...

Cervical cancer remains one of the most daunting diagnoses a woman can face: each year, over half a million new cases are detected worldwide, and many are only identified once symptoms appear. Advances in screening and vaccination have improved early detection, yet challenges persist – from navigating complex staging to...

Ovarian cancer is a significant global health concern, ranking as the eighth most common cancer among women. In 2022, there were approximately 324,603 new cases worldwide, with over 206,000 related deaths. The disease often presents with non-specific symptoms, leading to late-stage diagnoses and a global five-year survival rate ranging...